Patients who accepted infected kidneys cured of hepatitis C

August 6, 2018 by Emiliano Rodriguez Mega
Patients who accepted infected kidneys cured of hepatitis C
Kiran Shelat, a 65-year-old retired civil engineer, poses for a portrait in his home, Monday Aug. 6, 2018, in Yardley, Pa. Shebat had spent two years on a kidney transplant waiting list before signing up for a bold experiment with 19 others in which they received organs infected with hepatitis C. A study finds U.S. patients who accepted kidneys infected with hepatitis C were later cured. Results were published Monday in the journal Annals of Internal Medicine. (AP Photo/Jacqueline Larma)

Some patients in desperate need of a kidney transplant participated in a bold experiment where they received organs infected with hepatitis C. The gamble paid off.

Their new organs are working fine thanks to medication that got rid of the , researchers reported Monday.

It was a small study involving just 20 . But researchers say it suggests that organs currently going to waste just might help speed transplants for patients who wait years to get one.

"When there's such a bad organ shortage, we can't just do business as usual," said Dr. Peter Reese, a University of Pennsylvania specialist who led the study. "We need to shake off that these organs aren't valuable and that people will not want them."

In the United States, almost 95,000 people are on the national kidney waiting list but only 19,850 received a in 2017, according to the United Network for Organ Sharing. That only covers about 20 percent of all cases.

Hepatitis C is an infection that can quietly destroy someone's liver if untreated. Transplanting other organs from patients with the virus can infect the recipients. But with powerful new drugs now available that promise to cure them, Reese's team decided to test if it's safe to transplant infected kidneys to people who don't already have the virus —but who might not survive the wait for a healthy organ.

Twelve weeks of hepatitis treatment cleared the virus in all 20 patients tested so far. Compared to patients who received uninfected organs, their new kidneys work just as well, even a year after the procedure. Merck & Co., helped fund the research and provided the pills in the study. Results were published in the journal Annals of Internal Medicine.

Kiran Shelat, a 65-year-old civil engineer from Yardley, Pennsylvania, had spent two years on the transplant waiting list before signing up for the experiment.

He now feels energetic, and can work out in the gym and attend family events. So far, there's no sign of the virus in his bloodstream.

Patients who accepted infected kidneys cured of hepatitis C
Kiran Shelat, a 65-year-old retired civil engineer, poses for a portrait in his home, Monday Aug. 6, 2018, in Yardley, Pa. Shebat had spent two years on a kidney transplant waiting list before signing up for a bold experiment with 19 others in which they received organs infected with hepatitis C. A study finds U.S. patients who accepted kidneys infected with hepatitis C were later cured. Results were published Monday in the journal Annals of Internal Medicine. (AP Photo/Jacqueline Larma)

"This is a lifesaver," Shelat said. "Get off the list; get the kidney. There is nothing to be afraid of."

Transplant specialists are keeping a watchful eye.

"As long as the patient accepts the risk, I support this," said Dr. Josh Levitsky, a professor of organ transplantation at Northwestern University who is not part of the team.

Getting an infected kidney may outweigh the burden of dialysis, which many patients find physically exhausting, said Dr. Matthew Cooper, a transplant surgeon at Georgetown University Hospital.

"People have to plan their entire lives around dialysis," said Cooper, who was not part of the research. "It is a rotten lifestyle."

It costs about $88,000 a year to undergo dialysis, according to the United States Renal Data System. Merck has set a price of $54,600 for a round of its hepatitis C medication, Zepatier.

Most insurance companies still don't cover the drug for transplant patients, Reese said.

The American Society of Transplantation has said larger studies are needed before transplanting infected kidneys is done routinely.

In 2016, Johns Hopkins University launched a similar experiment with 10 people. All of them are now cured. Researchers in the United Kingdom are already discussing the possibility to use organs with hepatitis C in patients who don't have the virus.

Explore further: Using hepatitis C-infected donor kidneys could reduce time on dialysis for transplant patients with HCV

More information: Abstract: http://annals.org/aim/article/doi/10.7326/M18-0749

Editorial: http://annals.org/aim/article/doi/10.7326/M18-1781

Related Stories

Using hepatitis C-infected donor kidneys could reduce time on dialysis for transplant patients with HCV

July 9, 2018
Transplanting hepatitis C (HCV)-infected dialysis patients with organs from HCV-positive donors and then treating the infection after transplantation is more effective, costs less and will shorten wait times for donated organs, ...

Canadian team reports success in transplanting hepatitis C organs

June 14, 2018
A long-running shortage in donor organs has pushed doctors to find ways to use those with hepatitis C, an infection that is increasingly common in the United States due to the opioid crisis, and which can be cured with medicine.

Worth it? A faster transplant but a kidney with hepatitis C

October 27, 2016
A bold experiment is giving some patients a chance at cutting years off their wait for a kidney transplant if they agree to a drastic-sounding option—getting an organ almost sure to infect them with hepatitis C.

One year posttransplant, recipients of hepatitis C kidneys disease-free

March 5, 2018
In a small study, doctors at Johns Hopkins have successfully transplanted 10 hepatitis C-infected kidneys into patients without hepatitis C and prevented the patients from becoming infected by hepatitis C. The success of ...

Team eradicates hepatitis C in 10 patients following lifesaving transplants from infected donors

April 30, 2017
Ten patients at Penn Medicine have been cured of the Hepatitis C virus (HCV) following lifesaving kidney transplants from deceased donors who were infected with the disease. The findings point to new strategies for increasing ...

Transplanted livers help body defend against organ rejection, study finds

April 18, 2018
For decades, transplant experts have observed that liver transplant recipients often need less anti-rejection medication, known as immunosuppressive drugs, than recipients of other solid organs. Similarly, when patients receive ...

Recommended for you

Tibetan sheep highly susceptible to human plague, originates from marmots

August 16, 2018
In the Qinghai-Tibet plateau, one of the region's highest risk areas for human plague, Himalayan marmots are the primary carriers of the infectious bacterium Y. pestis. Y. pestis infection can be transmitted to humans and ...

Autoimmunity plays role in development of COPD, study finds

August 16, 2018
Autoimmunity plays a role in the development of chronic obstructive pulmonary disease (COPD), according to a study led by Georgia State University and Vanderbilt University Medical Center that analyzed human genome information ...

Scientists identify nearly 200 potential tuberculosis drug targets

August 16, 2018
Tuberculosis is one of the top 10 causes of death worldwide. Nearly 2 million people die every year from this infectious disease, and an estimated 2 billion people are chronically infected. The only vaccine, developed almost ...

Reliable point-of-care blood test can help prevent toxoplasmosis

August 16, 2018
A recent study, performed in Chicago and Rabat, Morocco, found that a novel finger-prick test for infection with the parasite Toxoplasma gondii during pregnancy—and many other potential applications—is 100 percent sensitive ...

First mouse model to mimic lung disease could speed discovery of more effective treatments

August 16, 2018
The biggest hurdle to finding effective therapies for idiopathic pulmonary fibrosis (IPF) – a life-threatening condition in which the lungs become scarred and breathing is increasingly difficult – has been the inability ...

Anticancer drug offers potential alternative to transplant for patients with liver failure

August 15, 2018
Patients suffering sudden liver failure could in the future benefit from a new treatment that could reduce the need for transplants, research published today shows.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.